Zenzedi (dextroamphetamine sulfate tablets) is an amphetamine for the treatment of narcolepsy. Zenzedi is also indicated as a treatment for attention deficit hyperactivity disorder (ADHD) in pediatric patients ages 3 to 16 years as an integral part of a total treatment program for ADHD that may include counseling or other therapies.
The usual dose of Zenzedi to treat narcolepsy is 5 to 60 mg per day in divided doses, depending on the individual patient response. The initial dose of Zenzedi to treat ADHD in pediatric patients 3 to 5 years of age is 2.5 mg daily, by tablet. In pediatric patients 6 years of age and older, the starting dose of Zenzedi is 5 mg once or twice daily.
What Drugs, Substances, or Supplements Interact with Zenzedi?
Zenzedi may interact with guanethidine, reserpine, glutamic acid HCl, ascorbic acid, fruit juices, ammonium chloride, sodium acid phosphate, adrenergic blockers, alkalinizing agents, tricyclic antidepressants, MAO inhibitors, antihistamines, antihypertensives, chlorpromazine, ethosuximide, haloperidol, lithium carbonate, meperidine, methenamine therapy, norepinephrine, phenobarbital, phenytoin, propoxyphene, and veratrum alkaloids. Tell your doctor all medications and supplements you use.
Zenzedi During Pregnancy or Breastfeeding
Zenzedi should only be used during pregnancy if prescribed; it is unknown how it might affect a fetus. Zenzedi passes into breast milk. Breastfeeding is not recommended while taking Zenzedi. Withdrawal symptoms may occur if you suddenly stop taking Zenzedi.
Additional Information
Our Zenzedi (dextroamphetamine sulfate tablets) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Zenzedi Consumer Information
Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
signs of heart problems--chest pain, trouble breathing, feeling like you might pass out;
signs of psychosis--hallucinations (seeing or hearing things that are not real), new behavior problems, aggression, hostility, paranoia;
signs of circulation problems--numbness, pain, cold feeling, unexplained wounds, or skin color changes (pale, red, or blue appearance) in your fingers or toes;
a seizure (convulsions);
muscle twitches (tics); or
changes in your vision.
Seek medical attention right away if you have symptoms of serotonin syndrome, such as: agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.
Dextroamphetamine can affect growth in children. Tell your doctor if your child is not growing at a normal rate while using this medicine.
Common side effects may include:
dry mouth, upset stomach, loss of appetite, weight loss;
headache, dizziness;
tremors, fast heartbeats; or
sleep problems (insomnia).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Psychotic episodes at recommended doses (rare),
overstimulation, restlessness, dizziness, insomnia, euphoria, dyskinesia,
dysphoria, tremor, headache, exacerbation of motor and phonic tics and
Tourette's syndrome.
Gastrointestinal
Dryness of the mouth, unpleasant taste, diarrhea,
constipation, other gastrointestinal disturbances. Anorexia and weight loss may
occur as undesirable effects.
Amphetamines have been extensively abused. Tolerance,
extreme psychological dependence and severe social disability have occurred.
There are reports of patients who have increased the dosage to many times that
recommended. Abrupt cessation following prolonged high dosage administration
results in extreme fatigue and mental depression; changes are also noted on the
sleep EEG.
Manifestations of chronic intoxication with amphetamines
include severe dermatoses, marked insomnia, irritability, hyperactivity and
personality changes. The most severe manifestation of chronic intoxication is
psychosis, often clinically indistinguishable from schizophrenia. This is rare
with oral amphetamines.
&Copy; Zenzedi Patient Information is supplied by Cerner Multum, Inc. and Zenzedi Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.
